about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionA Review of Integrative Medicine in Gynaecological OncologyNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskCandidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSGenome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Genome-wide association study identifies a common variant associated with risk of endometrial cancer.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Phenotyping sensory nerve endings in vitro in the mouse.Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerEstrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.Breast Cancer Risk - Genes, Environment and Clinics.Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerConsortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumEvidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM StudyFine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumTransient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskKnowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerCommon germline polymorphisms associated with breast cancer-specific survival.Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients.Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerIdentification of novel genetic markers of breast cancer survival.Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesGenome-wide association study identifies a possible susceptibility locus for endometrial cancer
P50
Q21134914-43DBD51C-4713-4A1A-8362-2F166D1CBFE1Q26768670-109A4CC8-004A-4EDD-8AF8-2E051506A82CQ26799669-8F7F365A-BB16-4BB6-BB57-EBB4DFEB2CF4Q28385765-36647EC0-4A67-475E-A1EF-8AE2B2F9AAD7Q28584533-806383FA-FD42-426A-B39F-B609B787D103Q29417100-4A675DC2-C2FF-46D4-9AF7-8189CEFE1F41Q29417135-F60EF83C-C929-49AF-801A-EC567F7F8699Q30252854-D90FA73F-0D50-416D-B2A6-BB37493AD74AQ30275832-90697383-0F20-448B-9D81-56BFB36E0C52Q30276986-C8EB8F47-168F-4F1F-9835-85C944300D0DQ30313653-97B7C718-B147-4144-8AB8-876A9CF75B53Q30374367-D126FC47-B2E9-4E36-9FCA-87BED6E04997Q31082788-7FBFBCEC-9A0B-4595-8F77-72A9BE963ECDQ31107007-82649DC9-28D2-4417-B5B5-88F966D8F9A6Q33778612-356B441C-81B6-4EE1-9307-EB363A42CBBBQ33847390-9279168D-C53E-4911-BF09-18FF824921EEQ33847791-6FE8B956-F3BF-476B-8469-5000E6870294Q33932856-8838E4A6-CDD3-447E-A5E0-EFB14DB91C35Q33947899-E2375F89-CF0E-40AE-81C2-6A0625AC6562Q34201805-C9B40010-48DF-41B3-92C4-357ED34CA3CFQ34209634-BE2D84D3-73A9-4152-BA10-AFF201ABCD5EQ34342248-8B3D1615-B2AF-4C35-B77B-8C3FC83B1FE7Q34379032-5B651D34-145F-46FA-9ED3-4BEE0CAD5861Q34687073-D50EF625-A34C-4306-88A6-984E78B368CDQ34764981-0E0D2FA1-B07D-4F00-8126-A5B7C59574A1Q35063160-AE13FE70-CF4C-457D-B134-16463BCF5AA5Q35119701-FAC7072F-4BB8-45F5-A323-CAB848748EC0Q35518269-37BE5E7E-BBB7-4615-A337-4D3D324FABB0Q35541663-F2E6C4BB-446C-4365-9BED-91956AD1F4FFQ35653910-08236FA7-0055-4DC7-8A2D-D41C7B9DFB01Q35668946-281941CB-2420-4C18-8E74-B0CB4B316122Q35745601-4666B6D2-BBEB-446D-9C2D-13A19A7E3E12Q35782435-8CC1A4A5-7634-467E-BE9D-B264DCFDCB35Q35794653-729A94F8-4863-4532-8D35-FB9304139EBFQ35815412-F2A5522B-3D19-43CB-BC17-E4D7269E809BQ35815464-A567D409-BBB7-458D-B743-53A2D40A14B6Q35996692-C7A62970-2679-494D-BCCF-91E4E559B303Q36014067-B214B236-D2E6-40B6-A584-0A622DC6D7C3Q36015063-A1CA5444-DFA5-4595-B9C1-DCFEB0F835C7Q36024614-7CFC96CF-8559-413C-9F59-1DE6D26D20CC
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Alexander Hein
@ast
Alexander Hein
@en
Alexander Hein
@es
Alexander Hein
@nl
Alexander Hein
@sl
type
label
Alexander Hein
@ast
Alexander Hein
@en
Alexander Hein
@es
Alexander Hein
@nl
Alexander Hein
@sl
prefLabel
Alexander Hein
@ast
Alexander Hein
@en
Alexander Hein
@es
Alexander Hein
@nl
Alexander Hein
@sl
P214
P1053
F-6999-2010
P106
P1153
35885462600
P21
P214
P31
P3829
P496
0000-0003-2601-3398
P735
P7859
viaf-103374156